Variant Creutzfeldt-Jakob disease and prions in the blood supply.
作者信息
Rohwer Robert G, Drohan William
机构信息
Molecular Neurovirology Unit, Baltimore VA Medical Center, USA.
出版信息
Clin Adv Hematol Oncol. 2004 Feb;2(2):84, 87, 131.
PMID:16163166
Abstract
摘要
相似文献
1
Variant Creutzfeldt-Jakob disease and prions in the blood supply.变异型克雅氏病与血液供应中的朊病毒
Clin Adv Hematol Oncol. 2004 Feb;2(2):84, 87, 131.
2
Blood-transmitted prions and variant Creutzfeldt-Jakob disease.血源性朊病毒与变异型克雅氏病
Biologicals. 2007 Apr;35(2):75-7. doi: 10.1016/j.biologicals.2007.01.005. Epub 2007 Feb 20.
3
Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.克雅氏病：关于血液制品治疗风险的思考
Haemophilia. 2007 Dec;13 Suppl 5:33-40. doi: 10.1111/j.1365-2516.2007.01572.x.
4
Removal of TSE agents from blood products.
Vox Sang. 2004 Jul;87 Suppl 2:7-10. doi: 10.1111/j.1741-6892.2004.00444.x.
5
6
Creutzfeldt-Jakob disease and the risk from blood or blood products.克雅氏病与血液或血液制品带来的风险。
Vox Sang. 1998;75(3):178-80.
7
Prions and transfusion medicine.
Vox Sang. 2000;78 Suppl 2:231-8.
8
9
Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15 years.克雅氏病通过血液及血液制品传播的风险。法国过去15年的风险分析。
Transfus Clin Biol. 2013 Sep;20(4):398-404. doi: 10.1016/j.tracli.2013.06.001. Epub 2013 Jul 30.
10
Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.管控血液制品传播变异型克雅氏病的风险。
Br J Haematol. 2006 Jan;132(1):13-24. doi: 10.1111/j.1365-2141.2005.05796.x.
Zotero 插件